View in EDS PDF Full Text

Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference.

Saved in:
Bibliographic Details
Title: Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference.
Authors: Zaiss AK; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Zuber J; Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, New York, New York, United States of America., Chu C; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Machado HB; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Jiao J; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Catapang AB; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Ishikawa TO; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Gil JS; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Lowe SW; Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, New York, New York, United States of America., Herschman HR; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Source: PloS one [PLoS One] 2014 Jul 02; Vol. 9 (7), pp. e101263. Date of Electronic Publication: 2014 Jul 02 (Print Publication: 2014).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24988319
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zaiss+AK%22">Zaiss AK</searchLink>; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Zuber+J%22">Zuber J</searchLink>; Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Chu+C%22">Chu C</searchLink>; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Machado+HB%22">Machado HB</searchLink>; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Jiao+J%22">Jiao J</searchLink>; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Catapang+AB%22">Catapang AB</searchLink>; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Ishikawa+TO%22">Ishikawa TO</searchLink>; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Gil+JS%22">Gil JS</searchLink>; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Lowe+SW%22">Lowe SW</searchLink>; Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Herschman+HR%22">Herschman HR</searchLink>; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2014 Jul 02; Vol. 9 (7), pp. e101263. <i>Date of Electronic Publication: </i>2014 Jul 02 (<i>Print Publication: </i>2014).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24988319
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0101263
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e101263
    Titles:
      – TitleFull: Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zaiss AK
      – PersonEntity:
          Name:
            NameFull: Zuber J
      – PersonEntity:
          Name:
            NameFull: Chu C
      – PersonEntity:
          Name:
            NameFull: Machado HB
      – PersonEntity:
          Name:
            NameFull: Jiao J
      – PersonEntity:
          Name:
            NameFull: Catapang AB
      – PersonEntity:
          Name:
            NameFull: Ishikawa TO
      – PersonEntity:
          Name:
            NameFull: Gil JS
      – PersonEntity:
          Name:
            NameFull: Lowe SW
      – PersonEntity:
          Name:
            NameFull: Herschman HR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 07
              Text: 2014 Jul 02
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1